BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 33046527)

  • 1. Changes in quality of life, cognition and functional status following catheter ablation of atrial fibrillation.
    Piccini JP; Todd DM; Massaro T; Lougee A; Haeusler KG; Blank B; de Bono JP; Callans DJ; Elvan A; Fetsch T; Van Gelder I; Gentlesk P; Grimaldi M; Hansen J; Hindricks G; Al-Khalidi H; Mont L; Nielsen JC; Noelker G; De Potter T; Scherr D; Schotten U; Themistoclakis S; Vijgen J; Di Biase L; Kirchhof P
    Heart; 2020 Dec; 106(24):1919-1926. PubMed ID: 33046527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeat Catheter Ablation of Long-standing Persistent Atrial Fibrillation in Patients with a Total Atrial Fibrillation Duration of More Than 2 Years: Effects of the CHA2DS2-VASc Score and Estimated Glomerular Filtration Rate on the Outcomes.
    Wang Q; Jiang SL; Liu X; Yang YQ
    Intern Med; 2016; 55(18):2537-47. PubMed ID: 27629945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of quality of life with procedural success of atrial fibrillation (AF) ablation and postablation AF burden: substudy of the STAR AF randomized trial.
    Mantovan R; Macle L; De Martino G; Chen J; Morillo CA; Novak P; Calzolari V; Khaykin Y; Guerra PG; Nair G; Torrecilla EG; Verma A
    Can J Cardiol; 2013 Oct; 29(10):1211-7. PubMed ID: 23988341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term quality of life after ablation of atrial fibrillation the impact of recurrence, symptom relief, and placebo effect.
    Wokhlu A; Monahan KH; Hodge DO; Asirvatham SJ; Friedman PA; Munger TM; Bradley DJ; Bluhm CM; Haroldson JM; Packer DL
    J Am Coll Cardiol; 2010 May; 55(21):2308-16. PubMed ID: 20488300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal rhythm-control strategy for recurrent atrial tachycardia after catheter ablation of persistent atrial fibrillation: a randomized clinical trial.
    Zhang XD; Gu J; Jiang WF; Zhao L; Zhou L; Wang YL; Liu YG; Liu X
    Eur Heart J; 2014 May; 35(20):1327-34. PubMed ID: 24497338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of quality of life, anxiety, and depression with left atrial ablation outcomes.
    Efremidis M; Letsas KP; Lioni L; Giannopoulos G; Korantzopoulos P; Vlachos K; Dimopoulos NP; Karlis D; Bouras G; Sideris A; Deftereos S
    Pacing Clin Electrophysiol; 2014 Jun; 37(6):703-11. PubMed ID: 24809737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of metabolic syndrome on procedural outcomes in patients with atrial fibrillation undergoing catheter ablation.
    Mohanty S; Mohanty P; Di Biase L; Bai R; Pump A; Santangeli P; Burkhardt D; Gallinghouse JG; Horton R; Sanchez JE; Bailey S; Zagrodzky J; Natale A
    J Am Coll Cardiol; 2012 Apr; 59(14):1295-301. PubMed ID: 22464257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of CHADS2, R2CHADS2, and CHA2DS2-VASc scores for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
    Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Huo Y; Piorkowski C; Bollmann A
    Circ Arrhythm Electrophysiol; 2014 Apr; 7(2):281-7. PubMed ID: 24610790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life and healthcare utilisation improvements after atrial fibrillation ablation.
    Gupta D; Vijgen J; Potter T; Scherr D; Van Herendael H; Knecht S; Kobza R; Berte B; Sandgaard N; Albenque JP; Széplaki G; Stevenhagen Y; Taghji P; Wright M; Duytschaever M
    Heart; 2021 Aug; 107(16):1296-1302. PubMed ID: 33952593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
    Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
    Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex differences in catheter ablation of atrial fibrillation: results from AXAFA-AFNET 5.
    Kloosterman M; Chua W; Fabritz L; Al-Khalidi HR; Schotten U; Nielsen JC; Piccini JP; Di Biase L; Häusler KG; Todd D; Mont L; Van Gelder IC; Kirchhof P;
    Europace; 2020 Jul; 22(7):1026-1035. PubMed ID: 32142113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction.
    Black-Maier E; Ren X; Steinberg BA; Green CL; Barnett AS; Rosa NS; Al-Khatib SM; Atwater BD; Daubert JP; Frazier-Mills C; Grant AO; Hegland DD; Jackson KP; Jackson LR; Koontz JI; Lewis RK; Sun AY; Thomas KL; Bahnson TD; Piccini JP
    Heart Rhythm; 2018 May; 15(5):651-657. PubMed ID: 29222043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in renal function after catheter ablation of atrial fibrillation are associated with CHADS2 and CHA2DS2-VASc scores and arrhythmia recurrences.
    Kornej J; Hindricks G; Banerjee A; Arya A; Sommer P; Rolf S; Husser D; Lip GY; Bollmann A
    Heart; 2015 Jan; 101(2):126-31. PubMed ID: 25281600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life changes in patients undergoing repeated catheter ablation for atrial fibrillation.
    Pezawas T; Ristl R; Schukro C; Schmidinger H
    Clin Res Cardiol; 2016 Jan; 105(1):1-9. PubMed ID: 26105951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Quality of Life and Procedural Outcome After Catheter Ablation for Atrial Fibrillation: A Secondary Analysis of a Randomized Clinical Trial.
    Terricabras M; Mantovan R; Jiang CY; Betts TR; Chen J; Deisenhofer I; Macle L; Morillo CA; Haverkamp W; Weerasooriya R; Albenque JP; Nardi S; Menardi E; Novak P; Sanders P; Verma A;
    JAMA Netw Open; 2020 Dec; 3(12):e2025473. PubMed ID: 33275151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation.
    Letsas KP; Efremidis M; Giannopoulos G; Deftereos S; Lioni L; Korantzopoulos P; Vlachos K; Xydonas S; Kossyvakis C; Sideris A
    Europace; 2014 Feb; 16(2):202-7. PubMed ID: 23813452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between quality of life and burden of recurrent atrial fibrillation following ablation: CAPCOST multicentre cohort study.
    Essebag V; Azizi Z; Alipour P; Khaykin Y; Leong-Sit P; Sarrazin JF; Sturmer M; Morillo C; Terricabras M; Amit G; Roux JF; Patterson S; Verma A
    Europace; 2020 Jul; 22(7):1017-1025. PubMed ID: 32531030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depression, anxiety, and quality of life after catheter ablation in patients with paroxysmal atrial fibrillation.
    Sang CH; Chen K; Pang XF; Dong JZ; Du X; Ma H; Liu JH; Ma CS; Sun YX
    Clin Cardiol; 2013 Jan; 36(1):40-5. PubMed ID: 22777577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in quality of life after catheter ablation for paroxysmal versus long-standing persistent atrial fibrillation: a prospective study with 3-year follow-up.
    Bulková V; Fiala M; Havránek S; Simek J; Skňouřil L; Januška J; Spinar J; Wichterle D
    J Am Heart Assoc; 2014 Jul; 3(4):. PubMed ID: 25037195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of improvement in arrhythmia-specific symptoms and health-related quality of life after catheter ablation of atrial fibrillation.
    Barmano N; Charitakis E; Karlsson JE; Nystrom FH; Walfridsson H; Walfridsson U
    Clin Cardiol; 2019 Feb; 42(2):247-255. PubMed ID: 30548275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.